FR2230374B1 - - Google Patents

Info

Publication number
FR2230374B1
FR2230374B1 FR7417965A FR7417965A FR2230374B1 FR 2230374 B1 FR2230374 B1 FR 2230374B1 FR 7417965 A FR7417965 A FR 7417965A FR 7417965 A FR7417965 A FR 7417965A FR 2230374 B1 FR2230374 B1 FR 2230374B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7417965A
Other languages
French (fr)
Other versions
FR2230374A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of FR2230374A1 publication Critical patent/FR2230374A1/en
Application granted granted Critical
Publication of FR2230374B1 publication Critical patent/FR2230374B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
FR7417965A 1973-05-23 1974-05-22 Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid Granted FR2230374A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36297173A 1973-05-23 1973-05-23

Publications (2)

Publication Number Publication Date
FR2230374A1 FR2230374A1 (en) 1974-12-20
FR2230374B1 true FR2230374B1 (en) 1978-07-21

Family

ID=23428261

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417965A Granted FR2230374A1 (en) 1973-05-23 1974-05-22 Phosphonates contg. a P-32 or P-33 radionuclide - prepd. by reaction of labelled phosphorus trichloride and acid

Country Status (6)

Country Link
BE (1) BE815397A (en)
DE (1) DE2424453C3 (en)
FR (1) FR2230374A1 (en)
NL (1) NL7406952A (en)
PH (1) PH12898A (en)
ZA (1) ZA743159B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767531B2 (en) 1999-07-11 2004-07-27 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7691985B2 (en) 1999-07-11 2010-04-06 Poniard Pharmaceuticals, Inc. Skeletal-targeted radiation to treat bone-associated pathologies

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6547816B1 (en) 1999-07-12 2003-04-15 Civatech Corporation Formable integral source material for medical devices
EP1426063A3 (en) * 2000-02-18 2004-07-14 Civatech Corporation Brachytherapy seeds and stents that can be activated by neutron rays
US7686756B2 (en) 2006-08-29 2010-03-30 Ciratech Oncology Brachytherapy devices and related methods and computer program products

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6767531B2 (en) 1999-07-11 2004-07-27 Neorx Corporation High dose radionuclide complexes for bone marrow suppression
US7691985B2 (en) 1999-07-11 2010-04-06 Poniard Pharmaceuticals, Inc. Skeletal-targeted radiation to treat bone-associated pathologies
US7696331B2 (en) 1999-07-11 2010-04-13 Poniard Pharmaceuticals, Inc. High dose radionuclide complexes for bone marrow treatment

Also Published As

Publication number Publication date
DE2424453A1 (en) 1974-12-12
ZA743159B (en) 1975-05-28
NL7406952A (en) 1974-11-26
BE815397A (en) 1974-11-22
DE2424453C3 (en) 1981-02-26
FR2230374A1 (en) 1974-12-20
DE2424453B2 (en) 1980-06-12
PH12898A (en) 1979-10-04

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AU476761B2 (en)
AU465372B2 (en)
AR201235Q (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU474838B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU450229B2 (en)
AU476714B2 (en)
AR201229Q (en)
AU472848B2 (en)
FR2230374B1 (en)
AU476696B2 (en)
AU466283B2 (en)
AR199451A1 (en)
AU477823B2 (en)
AU476873B1 (en)
AU477824B2 (en)
AU461342B2 (en)
AR195948A1 (en)
AR200256A1 (en)
AU471461B2 (en)

Legal Events

Date Code Title Description
ST Notification of lapse